Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitex simplicifolia extract is a botanical extract obtained from the leaves or dried ripe fruits of Vitex simplicifolia (often considered a variety of Vitex trifolia, known as Vitex trifolia var. simplicifolia), a tropical/subtropical shrub in the Lamiaceae family[2][4]. The extract contains a variety of phytochemicals, notably flavonoid derivatives (such as penduletin and artemetin), triterpenes, and other secondary metabolites[2][4]. Research demonstrates in vitro trypanocidal activity against Trypanosoma brucei rhodesiense, indicating potential as an antitrypanosomal agent, though clinical data are lacking[4]. Like other Vitex species, extracts are investigated for anti-inflammatory, antimicrobial, antioxidant, and cytotoxic properties[1]. Traditional uses may overlap with other Vitex species (such as for menstrual complaints), but such uses are inferred and not directly established for vitex simplicifolia extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitex simplicifolia extract.